A new opioid designed multiple ligand derived from the μ opioid agonist endomorphin-2 and the δ opioid antagonist pharmacophore Dmt-Tic

[1]  S. Salvadori,et al.  Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore. , 2007, Bioorganic & medicinal chemistry.

[2]  S. Salvadori,et al.  New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores. , 2006, Journal of medicinal chemistry.

[3]  S. Salvadori,et al.  6-N,N-Dimethylamino-2,3-naphthalimide: A New Environment-Sensitive Fluorescent Probe in δ- and μ-Selective Opioid Peptides , 2006 .

[4]  Eduard Schreibmann,et al.  18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  J. Neumeyer,et al.  Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at μ, δ, and κ opioid receptors , 2006 .

[6]  S. Salvadori,et al.  Potent Dmt-Tic Pharmacophoric d- and -Opioid Receptor Antagonists , 2005 .

[7]  R. Morphy,et al.  Designed multiple ligands. An emerging drug discovery paradigm. , 2005, Journal of medicinal chemistry.

[8]  Jie Wei,et al.  Structure-activity relationship of the novel bivalent and C-terminal modified analogues of endomorphin-2. , 2005, Bioorganic & medicinal chemistry letters.

[9]  H. Loh,et al.  Inhibition of Akt/Protein Kinase B Signaling by Naltrindole in Small Cell Lung Cancer Cells , 2004, Cancer Research.

[10]  Y. Fujita,et al.  Development of Potent Bifunctional Endomorphin-2 Analogues with Mixed μ-/δ-Opioid Agonist and δ-Opioid Antagonist Properties , 2004 .

[11]  Y. Tsuda,et al.  Novel 2′,6′-Dimethyl-l-Tyrosine-Containing Pyrazinone Opioid Mimetic μ-Agonists with Potent Antinociceptive Activity in Mice , 2004, Journal of Pharmacology and Experimental Therapeutics.

[12]  Y. Fujita,et al.  Oral bioavailability of a new class of micro-opioid receptor agonists containing 3,6-bis[Dmt-NH(CH(2))(n)]-2(1H)-pyrazinone with central-mediated analgesia. , 2004, Journal of medicinal chemistry.

[13]  P. Schiller,et al.  A chimeric opioid peptide with mixed μ agonist/δ antagonist properties , 2004 .

[14]  S. Salvadori,et al.  Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia. , 2003, Journal of medicinal chemistry.

[15]  Y. Sasaki,et al.  Endomorphin 2 analogues containing Dmp residue as an aromatic amino acid surrogate with high mu-opioid receptor affinity and selectivity. , 2003, Bioorganic & medicinal chemistry.

[16]  G. Pasternak,et al.  Genetic Dissociation of Opiate Tolerance and Physical Dependence in δ-Opioid Receptor-1 and Preproenkephalin Knock-Out Mice , 2002, The Journal of Neuroscience.

[17]  E. Robinson,et al.  N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligands. , 2002, Nuclear medicine and biology.

[18]  S. Salvadori,et al.  Evaluation of the Dmt-Tic pharmacophore: Conversion of a potent δ-opioid receptor antagonist into a potent δ agonist and ligands with mixed properties , 2002 .

[19]  D. Filliol,et al.  Immunosuppression by δ-Opioid Antagonist Naltrindole: δ- and Triple μ/δ/κ-Opioid Receptor Knockout Mice Reveal a Nonopioid Activity , 2001 .

[20]  Peter W. Schiller,et al.  The Opioid μ Agonist/δ Antagonist DIPP-NH2[Ψ] Produces a Potent Analgesic Effect, No Physical Dependence, and Less Tolerance than Morphine in Rats , 1999 .

[21]  A. Kastin,et al.  A potent and selective endogenous agonist for the µ-opiate receptor , 1997, Nature.

[22]  I. Sora,et al.  The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia. , 1997, European journal of pharmacology.

[23]  Brigitte L. Kieffer,et al.  Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene , 1996, Nature.

[24]  S. Salvadori,et al.  δ Opioidmimetic Antagonists: Prototypes for Designing a New Generation of Ultraselective Opioid Peptides , 1995, Molecular medicine.

[25]  W. E. Wilson,et al.  Interaction of deltorphin with opioid receptors: Molecular determinants for affinity and selectivity , 1993, Peptides.

[26]  P. Portoghese,et al.  Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. , 1991, The Journal of pharmacology and experimental therapeutics.

[27]  W. E. Wilson,et al.  Function of negative charge in the "address domain" of deltorphins. , 1991, Journal of medicinal chemistry.

[28]  S. Salvadori,et al.  Opioid peptides. Synthesis and biological properties of dermorphin related hexapeptides , 1990 .

[29]  W. E. Wilson,et al.  Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors. , 1989, The Journal of biological chemistry.

[30]  W. E. Wilson,et al.  Dimeric dermorphin analogues as mu-receptor probes on rat brain membranes. Correlation between central mu-receptor potency and suppression of gastric acid secretion. , 1989, The Journal of biological chemistry.

[31]  H. Fields,et al.  Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates F.G. Fang, H.L. Fields and N.M. Lee, J. Pharmacol. Exp. Ther., 238 (1986) 1039–1044 , 1986, Pain.

[32]  A. Konecka,et al.  Double-enkephalins—Synthesis, activity on guinea-pig ileum, and analgesic effect , 1982, Peptides.

[33]  D. Rodbard,et al.  Dimeric tetrapeptide enkephalins display extraordinary selectivity for the δ opiate receptor , 1982, Nature.

[34]  Tomoko Takahashi,et al.  The Steric Hindrance of the Stepwise Reaction of N-Carboxy α-Amino Acid Anhydride with the α-Amino Acid Ester , 1981 .

[35]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.